DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vivelle-DOT (Estradiol) - Asthenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Asthenia (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vivelle-DOT (Estradiol) where reactions include asthenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: female, weighing 45.4 kg (99.8 pounds)

Reactions: Weight Decreased, Tinnitus, Headache, Fatigue, Malaise, Dyspepsia, Neck Pain, Depression, Decreased Appetite, Nausea, Cognitive Disorder, Self Injurious Behaviour, Muscle Twitching, Tremor, Insomnia, Dehydration, Nervous System Disorder, Memory Impairment, Blood Pressure Decreased, Asthenia

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Tylenol; Aspirin



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2012-08-09

Patient: female

Reactions: Weight Decreased, Tinnitus, Nausea, Cognitive Disorder, Headache, Self Injurious Behaviour, Muscle Twitching, Tremor, Fatigue, Malaise, Dyspepsia, Insomnia, Memory Impairment, Depression, Asthenia, Blood Pressure Decreased, Decreased Appetite

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Aspirin; Tylenol



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2012-08-02

Patient: female

Reactions: Weight Decreased, Tinnitus, Nausea, Headache, Cognitive Disorder, Muscle Twitching, Tremor, Fatigue, Malaise, Dyspepsia, Insomnia, Depression, Memory Impairment, Blood Pressure Decreased, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Aspirin; Tylenol (Caplet)



Possible Vivelle-DOT side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-26

Patient:

Reactions: Syncope, Fatigue, Skin Burning Sensation, Dizziness, Expired Drug Administered, Depression, Asthenia, Drug Dispensing Error

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-17

Patient: female

Reactions: Fatigue, Drug Ineffective, Arthralgia, Asthenia, Feeling Abnormal, Dysthymic Disorder

Drug(s) suspected as cause:
Vivelle-DOT
    Dosage: 0.05 mg, qw2

Vivelle-DOT
    Dosage: 0.375 mg, unk

Vivelle-DOT
    Dosage: 0.05 mg, qw2

Other drugs received by patient: Prometrium



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2012-01-31

Patient: female

Reactions: Fatigue, Drug Ineffective, Arthralgia, Dysthymic Disorder, Asthenia, Feeling Abnormal

Drug(s) suspected as cause:
Vivelle-DOT
    Dosage: 0.375 mg, unk

Vivelle-DOT
    Dosage: 0.05 mg, qw2

Vivelle-DOT
    Dosage: 0.05 mg, qw2

Other drugs received by patient: Progesterone



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2012-01-12

Patient: female

Reactions: Drug Ineffective, Asthenia, Feeling Abnormal, Dysthymic Disorder

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Prometrium



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2011-12-02

Patient: female

Reactions: Drug Ineffective, Dysthymic Disorder, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Prometrium



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2011-11-22

Patient: female

Reactions: Drug Ineffective, Asthenia, Feeling Abnormal, Dysthymic Disorder

Drug(s) suspected as cause:
Vivelle-DOT

Other drugs received by patient: Prometrium



Possible Vivelle-DOT side effects in female

Reported by a physician from United States on 2011-11-11

Patient: female, weighing 63.9 kg (140.7 pounds)

Reactions: Dizziness, Feeling Abnormal, Asthenia, Blood Pressure Decreased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Vivelle-DOT
    Dosage: 0.05 mg
    Indication: Oestrogen Deficiency
    Start date: 2011-01-01
    End date: 2011-07-01

Vivelle-DOT
    Dosage: 0.05 mg, qw2
    End date: 2011-09-01



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-31

Patient: female

Reactions: Breast Pain, Migraine, Hot Flush, Alopecia, DRY Mouth, Asthenia, Vocal Cord Cyst

Drug(s) suspected as cause:
Fluoxetine HCL
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Depression

Vivelle-DOT
    Dosage: 0.1 mg, qw2

Vivelle-DOT
    Dosage: 0.075 mg, qw2

Vivelle-DOT
    Dosage: 0.075 mg, qw2

Other drugs received by patient: Cyclobenzaprine Hydrochloride; Cyclobenzaprine Hydrochloride; Cyclobenzaprine Hydrochloride



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-31

Patient: female

Reactions: Dizziness, Blood Pressure Decreased, Asthenia, Feeling Abnormal

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Vivelle-DOT



Possible Vivelle-DOT side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-31

Patient: female

Reactions: Breast Pain, Migraine, Hot Flush, Alopecia, DRY Mouth, Asthenia, Vocal Cord Cyst

Drug(s) suspected as cause:
Fluoxetine HCL
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Depression

Vivelle-DOT
    Dosage: 0.075 mg, qw2

Vivelle-DOT
    Dosage: 0.1 mg, qw2

Vivelle-DOT
    Dosage: 0.075 mg, qw2

Other drugs received by patient: Cyclobenzaprine Hydrochloride; Cyclobenzaprine Hydrochloride; Cyclobenzaprine Hydrochloride

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017